# A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract Surgery

> **NCT01605942** · PHASE1 · TERMINATED · sponsor: **Allergan** · enrollment: 8 (actual)

## Conditions studied

- Cataract

## Interventions

- **DRUG:** Dexamethasone Drug Delivery System
- **DRUG:** Placebo Drug Delivery System

## Key facts

- **NCT ID:** NCT01605942
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Study terminated due to corporate decision.
- **Last updated:** 2015-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01605942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01605942, "A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01605942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*